title: How to Treat INI1 Negative Non-Rhabdoid Tumours in Adolescents: Following Genotype or Histological Phenotype?
authors.forename: F
authors.initials: F
authors.lastname: Völker
authors.forename: I
authors.initials: I
authors.lastname: Kühnle
authors.forename: J
authors.initials: J
authors.lastname: Edler
authors.forename: H-U
authors.initials: HU
authors.lastname: Schildhaus
authors.forename: C
authors.initials: C
authors.lastname: Vokuhl
authors.forename: A
authors.initials: A
authors.lastname: Mohr
authors.forename: C
authors.initials: C
authors.lastname: Sahlmann
authors.forename: C M
authors.initials: CM
authors.lastname: Kramm
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D059248:Chemoradiotherapy; D004428:Ear Neoplasms / Q000235:genetics* / Q000473:pathology / Q000628:therapy*; D004431:Ear, External; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics; D005838:Genotype; D006801:Humans; D060046:Maintenance Chemotherapy / Q000379:methods; D008297:Male; D009303:Nasopharyngeal Neoplasms / Q000235:genetics* / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging; D010641:Phenotype; D018335:Rhabdoid Tumor / Q000235:genetics* / Q000473:pathology / Q000628:therapy*; D000071796:SMARCB1 Protein / Q000235:genetics*; D016896:Treatment Outcome
chemical_list: D000071796:SMARCB1 Protein; C513266:SMARCB1 protein, human